DCF
Income statement / Annual
Last year (2024), BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.'s total revenue was $14.20 M,
a decrease of 0.19% from the previous year.
In 2024, BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.'s net income was $21.06 M.
See BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
08/31/2024 |
08/31/2023 |
08/31/2022 |
08/31/2021 |
08/31/2020 |
08/31/2019 |
08/31/2018 |
| Operating Revenue |
$14.20 M |
$14.23 M |
-$13.29 M |
$21.66 M |
$1.12 M |
$11.62 M |
$12.03 M |
| Cost of Revenue |
$8.99 M
|
$1.63 M
|
$1.95 M
|
$1.90 M
|
$1.71 M
|
$1.78 M
|
$1.60 M
|
| Gross Profit |
$5.20 M
|
$12.59 M
|
-$15.24 M
|
$19.77 M
|
-$593.29 K
|
$9.84 M
|
$10.43 M
|
| Gross Profit Ratio |
0.37
|
0.89
|
1.15
|
0.91
|
-0.53
|
0.85
|
0.87
|
| Research and Development Expenses |
$0.00
|
$4.03
|
-$0.85
|
$1.30
|
$16.41
|
$0.25
|
$0.40
|
| General & Administrative Expenses |
$500.12 K
|
$497.75 K
|
$689.08 K
|
$624.40 K
|
$510.40 K
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$500.12 K
|
$497.75 K
|
$689.08 K
|
$624.40 K
|
$510.40 K
|
$0.25
|
$0.40
|
| Other Expenses |
$21.07 M
|
$15.06 M
|
-$26.96 M
|
$7.76 M
|
$3.61 M
|
$14.96 M
|
$14.87 M
|
| Operating Expenses |
$21.57 M
|
$513.82 K
|
$703.38 K
|
$636.75 K
|
$524.19 K
|
$4.86 M
|
$14.87 M
|
| Cost And Expenses |
$21.57 M
|
$513.82 K
|
$703.38 K
|
$636.75 K
|
$524.19 K
|
$9.84 M
|
$10.43 M
|
| Interest Income |
$17.09 M
|
$14.86 M
|
$11.94 M
|
$12.73 M
|
$12.72 M
|
$14.40 M
|
$0.00
|
| Interest Expense |
$3.39 M
|
$3.12 M
|
$1.47 M
|
$1.05 M
|
$1.34 M
|
$2.12 M
|
$0.00
|
| Depreciation & Amortization |
$40.82 M
|
$167.90 K
|
$228.49 K
|
$236.56 K
|
$206.30 K
|
$171.86 K
|
$0.00
|
| EBITDA |
$65.26 M |
$13.71 M |
-$13.99 M |
$21.03 M |
$597.34 K |
$2.87 M |
$7.19 M |
| EBITDA Ratio |
4.6
|
0.96
|
1.05
|
0.97
|
0.53
|
0.25
|
0.6
|
| Operating Income Ratio |
-1.15
|
0.96
|
1.05
|
0.97
|
0.53
|
0.43
|
0.6
|
| Total Other Income/Expenses Net |
$37.43 M
|
$1.63 M
|
-$1.47 M
|
$1.90 M
|
$1.71 M
|
-$2.12 M
|
-$2.35 M
|
| Income Before Tax |
$21.06 M
|
$13.71 M
|
-$13.99 M
|
$21.03 M
|
$597.34 K
|
$2.87 M
|
$7.19 M
|
| Income Before Tax Ratio |
1.48
|
0.96
|
1.05
|
0.97
|
0.53
|
0.25
|
0.6
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.19
|
$972.20 K
|
| Net Income |
$21.06 M
|
$13.71 M
|
-$13.99 M
|
$21.03 M
|
$597.34 K
|
$4.99 M
|
$6.22 M
|
| Net Income Ratio |
1.48
|
0.96
|
1.05
|
0.97
|
0.53
|
0.43
|
0.52
|
| EPS |
1.4 |
0.91 |
-0.93 |
1.4 |
0.0399 |
1.74 |
1.29 |
| EPS Diluted |
1.4 |
0.91 |
-0.93 |
1.4 |
0.0399 |
0.33 |
0.42 |
| Weighted Average Shares Out |
$15.00 M
|
$15.00 M
|
$15.00 M
|
$14.97 M
|
$14.96 M
|
$2.87 M
|
$4.84 M
|
| Weighted Average Shares Out Diluted |
$15.04 M
|
$15.00 M
|
$15.00 M
|
$14.97 M
|
$14.96 M
|
$14.96 M
|
$14.96 M
|
| Link |
|
|
|
|
|
|
|
